The year 2021 has seen a remarkable growth of the ophthalmic drug market in China. The market size of chemical drugs for eye diseases is estimated to exceed 3.5 billion yuan (circa 549 million USD), with a year-on-year growth of 1.89%.1
Ophthalmic Drugs: Market Numbers
Among the best-selling eye disease drugs, Naphazoline Hydrochloride, Chlorphenamine Maleate and Vitamin B12 Eye Drops took the champion with over 400 million yuan (about 62.76 million USD) in sales value.
There are 13 ophthalmic drugs which realizes more than 100 million yuan (about 15.68 million USD) in sales. The top four are all for relieving dry or tired eyes. Bendazac Lysine Eye Drops, for treating early-stage senile cataract, ranked the fifth. The other eight are mainly antibiotic eye drops.